(Total Views: 540)
Posted On: 03/08/2021 6:22:40 PM
Post# of 153767
Really see Dr.Breem(?) point about the larger trials giving more power to the statistics!
It also raises a red flag at least with me, might just be my understanding but the way Nader talks it’s like the FDA is suggesting portions of the trial design and yet when asked about trial design he says that you have to know your drug and you decide what it should do....these two things don’t add up .......we seem to swallow the FDA “guidance” hook line and sinker yet time and time again it seems to be screwing CYDY over.
Well with the knowledge available to us now this new primary looks doable.
Third times the charm?
It also raises a red flag at least with me, might just be my understanding but the way Nader talks it’s like the FDA is suggesting portions of the trial design and yet when asked about trial design he says that you have to know your drug and you decide what it should do....these two things don’t add up .......we seem to swallow the FDA “guidance” hook line and sinker yet time and time again it seems to be screwing CYDY over.
Well with the knowledge available to us now this new primary looks doable.
Third times the charm?
(1)
(0)
